DrugSupplement
SMOFlipid clinical trials
Also written Medium chain triglycerides.
Keep track of what changes. Save the SMOFlipid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
33 studies that test it; most in 2017 (4)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 28
Fresenius Kabi (4) · University of Florida (2) · Mayo Clinic (2) · Assiut University (2) · Mansoura University (2) · Indiana University (1) · Alexandria University (1) · Dr. Schär AG / SPA (1)
Often tested with
Tested in the same studies.
Soybean oil, phospholipid emulsion (4) · ClinOleic (1) · Fish oil triglycerides (1) · Fish Oils (1) · MCT/LCT/Fish Oil Omega-3 Fatty Acid Lipid Emulsion (1) · Lipofundin (1)
Studies
Open first, then newest update. How each study uses SMOFlipid is read from its arms, and is right about nine times in ten.
Testing it · 33
- Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsRecruitingPhase 4Fresenius KabiNCT06049680Written as SMOFlipid® (lipid injectable emulsion)
- Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDHEnrolling by invitationPhase 2Coordinación de Investigación en Salud, MexicoNCT04031508Written as lipid injectable emulsion with Fish oil
- Comparison of Intralipid With SMOF Lipid Following HSCTRecruitingNot applicableShahid Beheshti UniversityNCT06625372Written as SMOF lipid
- LIPIDS-P Trial Phase I/II TrialCompletedPhase 1/2University of FloridaNCT03405870Written as Smoflipid
- Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical NeonatesCompletedPhase 3Indiana UniversityNCT03387579Written as Smoflipid 20% Lipid Emulsion for Injection
- Intralipid Versus SMOFlipid in HPN PatientsCompletedNot applicableMayo ClinicNCT03773237Written as SMOFLipid
- Efficacy of SMOF Lipid in the Management of Acute Poisoning With CarbamazepineCompletedPhase 2Alexandria UniversityNCT06316362Written as SMOF lipid 20%
- Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of AgeTerminatedPhase 4Fresenius KabiNCT03563222Written as Smoflipid
- Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and InfantsTerminatedPhase 3Fresenius KabiNCT02579265Written as Smoflipid 20% (investigational lipid for parenteral nutrition)
- Lipid Emulsion Infusion and COVID-19 PatientsCompletedPhase 3Assiut UniversityNCT04957940Written as SMOFlipid
- Lipid Emulsion in Cardiac Valve Replacement SurgeryStatus unknownNot applicableAssiut UniversityNCT04951791Written as SMOFlipid
- Market Research - Acceptability Study for New MCT Fat ProductsCompletedNot applicableDr. Schär AG / SPANCT04309214Written as MCT fats
- Effects of Fat Emulsions on PNALD and Oxidative Stress in Premature InfantsStatus unknownPhase 4Shanghai Jiao Tong University School of MedicineNCT04277923Written as SMOFlipid
- MiCrobiome dieT StudyCompletedNot applicableUniversity of MinnesotaNCT03610477Written as Medium chain triglycerides
- Rate of Bronchopulmonary Dysplasia in Preterms Neonates: a Trial Comparing SMOFlipid and MedialipideWithdrawnPhase 4Hospices Civils de LyonNCT02853253Written as SMOFlipid®
- Evaluation of Medium Chain Triglycerides in a Mixed Racial Population of Patients: a Feasibility StudyCompletedNot applicableBoston Medical CenterNCT02783703Written as Medium chain triglycerides (MCT)
- The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With SepsisCompletedPhase 4Mansoura University Children HospitalNCT03275090Written as Smoflipid ®
- SMOFLipid in Patients Who Are Intralipid IntolerantWithdrawnPhase 4Mayo ClinicNCT03054948Written as SMOFLipid
- Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.CompletedNot applicableYale UniversityNCT01315171Written as Medium chain triglycerides
- Preventing Cholestasis Using SMOFLipid®CompletedPhase 4Medical University of ViennaNCT01585935Written as SMOFLIPID
See all 33 studies that test SMOFlipid →
Given in every arm · 1 — SMOFlipid is usual care beside what is tested
As the comparator · 1 — what is tested is compared with SMOFlipid
Codes
What other systems call SMOFlipid · ClinicalTrials.gg INT001400
- MeSH (NLM) C000709826SMOFlipidConfirmed ClinicalTrials.gov, NLM
- RxNorm 1310578One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000709826 | SMOFlipid | Confirmed ClinicalTrials.gov, NLM |
| RxNorm | 1310578 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.